Evaluation of lipid profile in patients with inflammatory bowel disease

• Autor(a) principal: Adorne, Elaine de Fatima
• Data de Publicação: 2016
• Outros Autores: Bodanese, Luiz Carlos
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Scientia Medica (Porto Alegre. Online)
• Texto Completo: https://revistaseletronicas.pucrs.br/scientiamedica/article/view/22964
• topic: doença de Crohn; retocolite ulcerativa; dislipidemias.

Aims: To evaluate the lipid profile and inflammatory parameters in patients with bowel disease, Crohn’s disease (CD), and ulcerative colitis (UC) and correlate them with disease activity levels.Methods: Cross-sectional study of patients followed up at the Inflammatory Bowel Disease Outpatient Clinic of São Lucas Hospital at Pontifícia Universidade Católica do Rio Grande do Sul, Brazil. The demographic, anthropometric, and metabolic characteristics of patients with chronic inflammatory disease were evaluated. Lipids and inflammatory parameters were evaluated as well as the correlation between the severity of inflammatory disease and metabolic parameters using the Harvey-Bradshaw index for CD and Truelove and Witts’ method for UC.Results: The study included 122 male and female patients with inflammatory bowel disease classified into CD (n=64) and UC (n=58). Women accounted for 54.1% of the sample, with a mean age of 41.6±12.6 years and a BMI of 25±4.4kg/m2. Low-density lipoprotein cholesterol (LDL-c) was significantly higher in UC than in CD (p=0.006). Higher C-reactive protein levels were associated with a more severe inflammatory process in CD patients (p=0.027) according to the Harvey-Bradshaw index. In UC, there was a weak correlation between disease activity and high-density lipoprotein cholesterol (HDL-c) (rs= -0.29; p=0.036) and between disease activity and total cholesterol (rs= -0.30; p=0.028) according to Truelove and Witts’ index. The HDL-c of about two thirds of the patients (67.6%) was below the recommended values.Conclusions: LDL-c was significantly higher in patients with UC than in those with CD. HDL-c was lower in patients with more severe inflammatory disease triggered by UC. Increased C-reactive protein levels in CD patients were associated with severity of the inflammatory process determined by the Harvey-Bradshaw index. The detection of these metabolic changes may help identify individuals with potential risk for cardiovascular events.